PTEN-deficient intestinal stem cells initiate intestinal polyposis

Xi C. He; Tong Yin; Justin C. Grindley; Qiang Tian; Toshiro Sato; W. Andy Tao; Raminarao Dirisina; Kimberly S. Porter-Westpfahl; Mark Hembree; Teri Johnson; Leanne M. Wiedemann; Terrence A. Barrett; Leroy Hood; Hong Wu; Linheng Li

doi:10.1038/ng1928

PTEN-deficient intestinal stem cells initiate intestinal polyposis

Xi C. He, Tong Yin, Justin C. Grindley, Qiang Tian, Toshiro Sato, W. Andy Tao, Raminarao Dirisina, Kimberly S. Porter-Westpfahl, Mark Hembree, Teri Johnson, Leanne M. Wiedemann, Terrence A. Barrett, Leroy Hood, Hong Wu, Linheng Li

Research output: Contribution to journal › Article › peer-review

374 Scopus citations

Abstract

Intestinal polyposis, a precancerous neoplasia, results primarily from an abnormal increase in the number of crypts, which contain intestinal stem cells (ISCs). In mice, widespread deletion of the tumor suppressor Phosphatase and tensin homolog (PTEN) generates hamartomatous intestinal polyps with epithelial and stromal involvement. Using this model, we have established the relationship between stem cells and polyp and tumor formation. PTEN helps govern the proliferation rate and number of ISCs and loss of PTEN results in an excess of ISCs. In PTEN-deficient mice, excess ISCs initiate de novo crypt formation and crypt fission, recapitulating crypt production in fetal and neonatal intestine. The PTEN-Akt pathway probably governs stem cell activation by helping control nuclear localization of the Wnt pathway effector β-catenin. Akt phosphorylates β-catenin at Ser552, resulting in a nuclear-localized form in ISCs. Our observations show that intestinal polyposis is initiated by PTEN-deficient ISCs that undergo excessive proliferation driven by Akt activation and nuclear localization of β-catenin.

Original language	English
Pages (from-to)	189-198
Number of pages	10
Journal	Nature Genetics
Volume	39
Issue number	2
DOIs	https://doi.org/10.1038/ng1928
State	Published - Feb 2007

Bibliographical note

Funding Information:
We are grateful to B. Neaves and R. Krumlauf for scientific support. We thank H. Okano for providing anti-Musashi1 (14-H1) and A. Ouellette for anti-cryptdin; S. Peck and G. Yang for comments on the manuscript; D. di Natale for assistance on manuscript editing; P. Kulesa and D. Stark for imaging assistance; C. Seidel, K. Zueckert-Gaudenz and M. Coleman for assistance in microarray analysis; H. Marshall for technology support and J. Chen for assistance in statistical analysis. L. Li is supported in part by research grant 5-FY05-31 from the March of Dimes Birth Defects Foundation, by grant R01 DK070001 from the National Institute of Diabetes and Digestive and Kidney Diseases and by the Stowers Institute for Medical Research.

ASJC Scopus subject areas

Genetics

Access to Document

10.1038/ng1928

Cite this

@article{187727ca5a1f421aa0201f2208c6e3ff,

title = "PTEN-deficient intestinal stem cells initiate intestinal polyposis",

abstract = "Intestinal polyposis, a precancerous neoplasia, results primarily from an abnormal increase in the number of crypts, which contain intestinal stem cells (ISCs). In mice, widespread deletion of the tumor suppressor Phosphatase and tensin homolog (PTEN) generates hamartomatous intestinal polyps with epithelial and stromal involvement. Using this model, we have established the relationship between stem cells and polyp and tumor formation. PTEN helps govern the proliferation rate and number of ISCs and loss of PTEN results in an excess of ISCs. In PTEN-deficient mice, excess ISCs initiate de novo crypt formation and crypt fission, recapitulating crypt production in fetal and neonatal intestine. The PTEN-Akt pathway probably governs stem cell activation by helping control nuclear localization of the Wnt pathway effector β-catenin. Akt phosphorylates β-catenin at Ser552, resulting in a nuclear-localized form in ISCs. Our observations show that intestinal polyposis is initiated by PTEN-deficient ISCs that undergo excessive proliferation driven by Akt activation and nuclear localization of β-catenin.",

author = "He, {Xi C.} and Tong Yin and Grindley, {Justin C.} and Qiang Tian and Toshiro Sato and Tao, {W. Andy} and Raminarao Dirisina and Porter-Westpfahl, {Kimberly S.} and Mark Hembree and Teri Johnson and Wiedemann, {Leanne M.} and Barrett, {Terrence A.} and Leroy Hood and Hong Wu and Linheng Li",

note = "Funding Information: We are grateful to B. Neaves and R. Krumlauf for scientific support. We thank H. Okano for providing anti-Musashi1 (14-H1) and A. Ouellette for anti-cryptdin; S. Peck and G. Yang for comments on the manuscript; D. di Natale for assistance on manuscript editing; P. Kulesa and D. Stark for imaging assistance; C. Seidel, K. Zueckert-Gaudenz and M. Coleman for assistance in microarray analysis; H. Marshall for technology support and J. Chen for assistance in statistical analysis. L. Li is supported in part by research grant 5-FY05-31 from the March of Dimes Birth Defects Foundation, by grant R01 DK070001 from the National Institute of Diabetes and Digestive and Kidney Diseases and by the Stowers Institute for Medical Research.",

year = "2007",

month = feb,

doi = "10.1038/ng1928",

language = "English",

volume = "39",

pages = "189--198",

number = "2",

}

TY - JOUR

T1 - PTEN-deficient intestinal stem cells initiate intestinal polyposis

AU - He, Xi C.

AU - Yin, Tong

AU - Grindley, Justin C.

AU - Tian, Qiang

AU - Sato, Toshiro

AU - Tao, W. Andy

AU - Dirisina, Raminarao

AU - Porter-Westpfahl, Kimberly S.

AU - Hembree, Mark

AU - Johnson, Teri

AU - Wiedemann, Leanne M.

AU - Barrett, Terrence A.

AU - Hood, Leroy

AU - Wu, Hong

AU - Li, Linheng

N1 - Funding Information: We are grateful to B. Neaves and R. Krumlauf for scientific support. We thank H. Okano for providing anti-Musashi1 (14-H1) and A. Ouellette for anti-cryptdin; S. Peck and G. Yang for comments on the manuscript; D. di Natale for assistance on manuscript editing; P. Kulesa and D. Stark for imaging assistance; C. Seidel, K. Zueckert-Gaudenz and M. Coleman for assistance in microarray analysis; H. Marshall for technology support and J. Chen for assistance in statistical analysis. L. Li is supported in part by research grant 5-FY05-31 from the March of Dimes Birth Defects Foundation, by grant R01 DK070001 from the National Institute of Diabetes and Digestive and Kidney Diseases and by the Stowers Institute for Medical Research.

PY - 2007/2

Y1 - 2007/2

N2 - Intestinal polyposis, a precancerous neoplasia, results primarily from an abnormal increase in the number of crypts, which contain intestinal stem cells (ISCs). In mice, widespread deletion of the tumor suppressor Phosphatase and tensin homolog (PTEN) generates hamartomatous intestinal polyps with epithelial and stromal involvement. Using this model, we have established the relationship between stem cells and polyp and tumor formation. PTEN helps govern the proliferation rate and number of ISCs and loss of PTEN results in an excess of ISCs. In PTEN-deficient mice, excess ISCs initiate de novo crypt formation and crypt fission, recapitulating crypt production in fetal and neonatal intestine. The PTEN-Akt pathway probably governs stem cell activation by helping control nuclear localization of the Wnt pathway effector β-catenin. Akt phosphorylates β-catenin at Ser552, resulting in a nuclear-localized form in ISCs. Our observations show that intestinal polyposis is initiated by PTEN-deficient ISCs that undergo excessive proliferation driven by Akt activation and nuclear localization of β-catenin.

AB - Intestinal polyposis, a precancerous neoplasia, results primarily from an abnormal increase in the number of crypts, which contain intestinal stem cells (ISCs). In mice, widespread deletion of the tumor suppressor Phosphatase and tensin homolog (PTEN) generates hamartomatous intestinal polyps with epithelial and stromal involvement. Using this model, we have established the relationship between stem cells and polyp and tumor formation. PTEN helps govern the proliferation rate and number of ISCs and loss of PTEN results in an excess of ISCs. In PTEN-deficient mice, excess ISCs initiate de novo crypt formation and crypt fission, recapitulating crypt production in fetal and neonatal intestine. The PTEN-Akt pathway probably governs stem cell activation by helping control nuclear localization of the Wnt pathway effector β-catenin. Akt phosphorylates β-catenin at Ser552, resulting in a nuclear-localized form in ISCs. Our observations show that intestinal polyposis is initiated by PTEN-deficient ISCs that undergo excessive proliferation driven by Akt activation and nuclear localization of β-catenin.

UR - http://www.scopus.com/inward/record.url?scp=33846600427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846600427&partnerID=8YFLogxK

U2 - 10.1038/ng1928

DO - 10.1038/ng1928

M3 - Article

C2 - 17237784

AN - SCOPUS:33846600427

SN - 1061-4036

VL - 39

SP - 189

EP - 198

JO - Nature Genetics

JF - Nature Genetics

IS - 2

ER -

PTEN-deficient intestinal stem cells initiate intestinal polyposis

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this